NEW YORK, April 2, 2015 /PRNewswire/ -- The Law Offices of
Vincent Wong are investigating
potential claims against the Board of Directors of Hyperion
Therapeutics, Inc. (NASDAQ: HPTX) ("Hyperion" or "the Company") in
connection with the sale of the Company to Horizon Pharma.
Click here to learn about the case:
http://docs.wongesq.com/HPTX-Info-Request-Form-667. There is
no cost or obligation to you.
Under the terms of the transaction, Hyperion shareholders will
receive $46.00 in cash for each share
of Hyperion stock they own. The investigation concerns whether the
Board of Hyperion breached their fiduciary duties to stockholders
by failing to adequately shop the Company before agreeing to enter
into this transaction, and whether Horizon Pharma is underpaying
for Hyperion shares.
If you own common stock in Hyperion and wish to obtain
additional information, please contact Vincent Wong, Esq. either via email
vw@wongesq.com, by telephone at 212.425.1140, or visit
http://docs.wongesq.com/HPTX-Info-Request-Form-667.
Vincent Wong, Esq. is an
experienced attorney that has represented investors in securities
litigations involving financial fraud and violations of shareholder
rights. Attorney advertising. Prior results do not guarantee
similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
Logo - http://photos.prnewswire.com/prnh/20140904/143045
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/hptx-shareholder-alert-the-law-offices-of-vincent-wong-launches-an-investigation-of-the-board-of-directors-of-hyperion-therapeutics-inc-concerning-the-sale-of-the-company-to-horizon-pharma--hptx-300060527.html
SOURCE The Law Offices of Vincent
Wong